You have 9 free searches left this month | for more free features.

Cobicistat mixture with darunavir

Showing 1 - 25 of 1,031

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19

Completed
  • Coronavirus
  • +2 more
  • Doha, Qatar
    Hamad Medical Corporation
Aug 15, 2022

Healthy Trial in Edegem (DRV/COBI FDC, COBI, DRV)

Completed
  • Healthy
  • DRV/COBI FDC
  • +2 more
  • Edegem, Belgium
    SGS Belgium NV
Oct 25, 2022

HIV Infected Population With Latent Tuberculosis Trial run by the CC (rifapentene (RPT), darunavir/cobicistat (DRV/c), Isoniazid

Completed
  • HIV Infected Population With Latent Tuberculosis
  • rifapentene (RPT)
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 15, 2022

HIV-1 Infection Trial in All The Regions Of The Country (40 Centers) (Dolutegravir, Darunavir-cobicistat,

Completed
  • HIV-1 Infection
  • All The Regions Of The Country (40 Centers), France
    (unnamed)
Jan 3, 2022

Human Immunodeficiency Virus (HIV) Trial in South Africa, Spain, United States (DRV/COBI FDC)

Recruiting
  • Human Immunodeficiency Virus (HIV)
  • DRV/COBI FDC
  • Atlanta, Georgia
  • +5 more
Aug 2, 2022

HIV-1-infection Trial in Saint Louis (Biktarvy Tab)

Terminated
  • HIV-1-infection
  • Biktarvy Tab
  • Saint Louis, Missouri
    Southampton Healthcare, Inc.
Jan 3, 2023

Healthy Trial in Groningen (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC, Darunavir, Emtricitabine/Tenofovir

Completed
  • Healthy
  • Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC
  • +3 more
  • Groningen, Netherlands
    PRA Health Sciences Onderzoekscentrum Groningen, locatie Martini
Aug 3, 2021

HIV, Obesity Trial in Greenville (Biktarvy, Symtuza)

Not yet recruiting
  • HIV Infections
  • Obesity
  • Greenville, North Carolina
    Adult Specialty Care Clinic-East Carolina University
Jul 14, 2022

Acquired Immune Deficiency Syndrome (AIDS), HIV Trial in Worldwide (ATV, DRV, Cobicistat)

Recruiting
  • Acquired Immune Deficiency Syndrome (AIDS)
  • HIV Infections
  • Long Beach, California
  • +29 more
Aug 18, 2022

Healthy Trial in Merksem (Dabigatran Etexilate, DRV/COBI, Ritonavir)

Completed
  • Healthy
  • Dabigatran Etexilate
  • +3 more
  • Merksem, Belgium
    Clinical Pharmacology Unit
Jun 8, 2021

HIV-1 Trial in Spain, United States (D/C/F/TAF FDC )

Completed
  • HIV-1
  • D/C/F/TAF FDC placebo
  • Phoenix, Arizona
  • +7 more
Jul 1, 2021

Healthy Trial in Groningen (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC, Darunavir, Emtricitabine/Tenofovir

Terminated
  • Healthy
  • Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC
  • +3 more
  • Groningen, Netherlands
    PRA Health Sciences Onderzoekscentrum Groningen, locatie Martini
Jul 3, 2020

Human Immunodeficiency Virus Type 1 Trial in Worldwide (D/C/F/TAF, Boosted Protease Inhibitor (bPI), FTC/TDF)

Completed
  • Human Immunodeficiency Virus Type 1
  • Phoenix, Arizona
  • +81 more
Nov 25, 2021

Pneumonia, Pneumocystis, Coronavirus Trial in Shanghai (Darunavir and Cobicistat)

Unknown status
  • Pneumonia, Pneumocystis
  • Coronavirus
  • Darunavir and Cobicistat
  • Shanghai, Shanghai, China
  • +1 more
Apr 9, 2020

Effect on HIV Medications on EPC Cells

Completed
  • AIDS
  • Washington, District of Columbia
    The GW Medical Faculty Associates
Mar 21, 2022

Antiretroviral Drugs and Related Drugs During and After

Completed
  • HIV Infections
  • Birmingham, Alabama
  • +61 more
Jun 28, 2022

Participants Taking Darunavir/ Cobicistat Plus Emtricitabine and

Completed
  • Human Immunodeficiency Virus (HIV)
  • D/C/F/TAF Fixed-Dose Combination (FDC)
  • Bergamo, Italy
  • +17 more
Nov 24, 2020

Human Immunodeficiency Virus Trial in Oakland Park (Symtuza)

Terminated
  • Human Immunodeficiency Virus
  • Oakland Park, Florida
    Midland Research Group, Inc
Dec 3, 2021

HIV-1-infection, Antiviral Drug Adverse Reaction, Vascular Diseases Trial in Augusta (Dolutegravir 50 MG, Antiretroviral/Anti

Unknown status
  • HIV-1-infection
  • +7 more
  • Dolutegravir 50 MG
  • Antiretroviral/Anti HIV
  • Augusta, Georgia
    Augusta University
Jan 11, 2021

HIV/AIDS Trial in Worldwide (Biktarvy, Symtuza)

Recruiting
  • HIV/AIDS
  • Antwerp, Belgium
  • +47 more
Jan 9, 2023

HIV-1 Trial in United States (DRV 800 mg + COBI 150 mg + FTC 200 mg + TAF 10 mg FDC)

Completed
  • HIV-1
  • DRV 800 mg + COBI 150 mg + FTC 200 mg + TAF 10 mg FDC
  • Phoenix, Arizona
  • +15 more
Sep 2, 2020

Darunavir/Cobicistat Containing Regimens in Routine Clinical

Completed
  • HIV Infections
    • Malaga, Marbella, Spain
    • +19 more
    Feb 3, 2020

    NSCLC Trial (Cobicistat)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • (no location specified)
    Feb 17, 2023

    Healthy Participants Trial in Miami (Atazanavir, Cobicistat, Atazanavir/Cobicistat Mini-tablet)

    Completed
    • Healthy Participants
    • Miami, Florida
      Local Institution - 0001
    Oct 27, 2022